On favorable news regarding phase 1 005 trial at the 2017 SanAntonio Breast Cancer Symposium.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
